StockSelector.com
  Research, Select, & Monitor Thursday, September 20, 2018 2:57:31 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
BioMarin Pharmaceutical, Inc.$100.92$1.151.15%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

BioMarin Pharmaceutical, Inc. has an overall rank of 1091 out of 7248 stocks based on 11 positive rankings and 7 negative rankings.

Positive Rankings
SSValue
The StockSelector Value for BioMarin Pharmaceutical is $1,111.81. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, BioMarin Pharmaceutical is ranked 87.
PEGValue
BioMarin Pharmaceutical has a PEG Value of $460.45. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 361.51% in the next year. Among companies with a PEG Value above the current stock price, BioMarin Pharmaceutical is ranked 134.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, BioMarin Pharmaceutical is ranked 422.
Target Prices
The average analysts' target price is $114.00 for BioMarin Pharmaceutical using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, BioMarin Pharmaceutical is ranked 499.
Historic Revenue Growth
BioMarin Pharmaceutical rank is 643
Highest Cash Growth
BioMarin Pharmaceutical rank is 732
Estimated Revenue Growth
BioMarin Pharmaceutical rank is 837
10 Day Gain
BioMarin Pharmaceutical rank is 1084
Up EPS Surprise
BioMarin Pharmaceutical beat the consensus earnings estimate when it last reported quarterly earnings.
90 Day Gain
BioMarin Pharmaceutical rank is 1090
Debt-to-Equity
BioMarin Pharmaceutical rank is 1414
Negative Rankings
High vPut/Call
BioMarin Pharmaceutical has a high Put/Call ratio of 10.57 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, BioMarin Pharmaceutical is ranked 76.
Price-to-Sales
BioMarin Pharmaceutical rank is 451
Overbought Stochastics
BioMarin Pharmaceutical rank is 772
Price-to-Book
BioMarin Pharmaceutical rank is 841
Negative Net Margin
BioMarin Pharmaceutical rank is 1132
Negative ROE
BioMarin Pharmaceutical rank is 1383
Negative ROA
BioMarin Pharmaceutical rank is 1594







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.